Introduction
For more than 15 years, the targeted temperature management (TTM) procedure has been used to treat patients after sudden out-of-hospital cardiac arrest (OHCA). As demonstrated by numerous clinical studies and meta-analyses, this is the only known effective neuroprotection method, used to improve neurological status and reduce mortality [1, 2] .
Most of the studies on TTM comes from intensive care units (ICU) with an anesthesiological profile, with access to mechanical ventilation and personnel with extensive knowledge on the treatment of post-cardiac arrest syndrome (PCAS).
Since 2012, it is observed, based on data from the Polish Registry of Therapeutic Hypothermia, that in addition to the typical OHCA patients treated in the ICU, a very large group consists of patients treated in intensive cardiac care units (ICCU). This is understandable as, according to current guidelines, every OHCA patient, especially with the defibrillation rhythm (ventricular fibrillation (VF) or ventricular tachycardia (VT)), should first of all have a coronary angiography to rule-out a coronary reason for the CA [3] . What is more, changes typical of acute coronary syndrome are often registered in the first ECG recordings, which require urgent coronary angiography and the invasive treatment of coronary artery disease. This approach broadens the spectrum of the treatment of patients with PCAS with typical cardiological procedures and pharmacotherapy, including treatment of myocardial infarction, heart failure, cardiogenic shock or arrhythmias. Current standards specifying requirements as to the equipment possessed and the qualifications of medical personnel have made ICCU gradually take over the full care of OHCA patients [4] .
To date, there have been no papers directly comparing the results of the treatment of OHCA patients between ICU and ICCU. The Polish Registry of Therapeutic Hypothermia provides such an opportunity. It was created to assess the need for TTM on a national scale, as well as to set rules for refunding the costs of the procedure [5] .
The aim of the current analysis was to compare the results of TTM procedure between cardiological (ICCU) and anesthesiological (ICU) departments.
Methods

Study population
The Polish Registry of Therapeutic Hypothermia gathered data on 377 OHCA patients from a total of 26 centers (16 ICCU and 10 ICU). Most of the patients (257) were treated in ICCU, while 120 patients in ICU. Each OHCA patient had completed a protocol for the TTM approved in Poland. The data on OHCA patient was then registered in the electronic case report form (eCRF).
Study design
Qualification for the TTM was based on the current inclusion criteria for the therapy, and each time the patient had to meet all inclusion points, with a total absence of contraindications (Table 1) .
Anonymous information included, but was not limited to, data on demographic data, medical history, place and circumstances of the OHCA episode, presence of witnesses and confirmation of performed cardiopulmonary resuscitation (CPR), baseline heart rhythm, delayed time to start CPR, duration of CPR until return of spontaneous circulation (ROSC), and evaluation of neurological condition at the time of admission to the hospital.
The additional part of the eCRF contained data on initial diagnosis and reason for OHCA treatment, in particular data on coronary angiography and the type of coronary intervention undertaken. A separate section contained data on the TTM procedure itself: the initial temperature, confirmed receipt of cold saline infusion, the type of cooling method, initial pharmacotherapy, target temperature (all centers assumed 33°C for the target cooling temperature) and duration of treatment, including the slow heating phase until the physiological temperature was reached. An important part of the eCRF concerned in-hospital complications and side effects of the TTM, as well as all-cause death. Hemorrhagic complications were assessed using the REPLACE 2 scale [6] .
Shock without specifying its cause was diagnosed in the case of persistent hypotension that fulfilled the following conditions: systolic blood pressure <90 mm Hg, mean blood pressure <65 mm Hg, or decrease in systolic blood pressure by >40 mm Hg in relation to the baseline value. The neurological status was evaluated 48 hours after the completion of infusion of sedatives, and then at the time of hospital discharge. The basis for the neurological assessment was Glasgow Coma Scale (GCS) and 6-point Rankin scale (7) , assuming that class 1 or 2 (small degree of disability) and class 4 or 5 (a very severe degree of disability), correspond with a good and bad neurological outcome, respectively.
Statistical analysis
Distributions of continuous variables were assessed with Shapiro-Wilk test. For all continuous variables non-normal distributions were revealed. Continuous and categorical variables were presented as median, interquartile range (IQR) and percentages, respectively. 
Differences between continuous variables were calculated with
Results
Patients in both ICU and ICCU groups were mostly males, with a mean age of 60 years. There were no significant differences regarding the medical history, mechanism of arrhythmia responsible for OHCA, time of CPR activities, or the time of ROSC. In the ICU group, OHCA more frequently occurred at home (p=0.047), while the ICCU group was more likely to have diagnosed ST-segment elevation myocardial infarction (STEMI) (p=0.002).
Both groups did not differ significantly in terms of the initial GCS score or in terms of times measured from the moment of connection to the cooling device to the target temperature (33°C), whereas in the ICCU group the period of primary cooling was statistically longer (Table 2) .
Looking at the applied treatment, it can be concluded that coronary angiography and coronary angioplasty were more frequently performed in the ICCU patients and, therefore, more often received dual antiplatelet therapy. Intra-aortic balloon pump (IABP) or devices for intravascular hypothermia more frequently were used in the ICCU group, while sedatives in the ICU patients. The most commonly used catecholamine in the ICU was norepinephrine, while in the ICCU dopamine and dobutamine. Prophylactic use of antibiotics was similar in both departments ( Table 2) .
Regarding the reported complications, a significant difference was observed in the number of cases of pneumonia and acute renal failure which occurred more frequently in the ICCU group (p=0.009, and p=0.05, respectively). During treatment, death occurred in 17% and 20% of the ICU and ICCU patients (p = 0.57), respectively. The most important risk factors for death for each group were identified using the univariable logistic regression method ( Table 3 ).
The neurological status of patients was assessed after 48 hours from the moment of discontinuation of sedation and at discharge from the hospital. The first neurological assessment revealed that most of the patients were in class 3 and 4 in the Rankin scale (ICCU and ICU, respectively). The discharge results of the Rankin scale were comparable for both departments: 33% of ICCU and 27% of ICU patients obtained a good Rankin score (class 1 or 2), while a very severe degree of disability (class 5 or 6) was assessed in 19.8% and 15.5% of patients, respectively. The remaining group were patients classified as class 3 (Figure 1 and In the univariable analysis, independent clinical factors that had the greatest impact on the neurological outcomes of the treated patients were identified and are shown in Table 4 .
Discussion
Treatment of OHCA patients is challenging and requires appropriate organization of departments, access to specialized equipment enabling the TTM procedure, as well as highlevel skills and knowledge of individual members of therapeutic teams. Based on the data from the Polish Registry of Therapeutic Hypothermia, cardiologists are increasingly using this method of treatment. An additional advantage of ICCU is the accessibility of coronary angiography, IABP and electrotherapy [8] . The registry gives the opportunity to compare the results of treatment between ICCU and ICU. In the authors' opinion this analysis is pioneering.
The current study did not show any significant differences in the final neurological outcome and the number of deaths. However, it is worth noting some important differences regarding the mode of treatment of OHCA patients. After ROSC, the ICCU patients received an infusion of cold saline significantly faster and were faster connected to the cooling device than ICU patients, but the total time to reach the target temperature (33°C) was similar in both groups. As shown by the results of previous studies on hypothermia, the time from CPR start to ROSC or the time from ROSC to achieve hypothermia and reach the target temperature is not prognostic [9] , and it appears that in our study they did not affect the final neurological outcome either. We observed that important factors which increased the risk of death in both groups were typical clinical factors, such as age of the patient, GCS score after CPR, the first recorded rhythm as defibrillation rhythm, and shock on hospital admission. In addition, in the ICCU group, the presence of third parties during OHCA proved to be a factor reducing mortality. Similar risk factors are also provided by the authors of a series of TTM studies [10] .
In the current study, a significant advantage was found in the use of intravascular TTM in the ICCU group. The Gillies et al study published in 2012 proved that both methods -external and endovascular -are equivalent in terms of treatment results with the same level of safety [11] . It can therefore be assumed that the imbalance in the current study regarding the applied cooling methods was not likely to affect the final results of the current analysis.
Our study also observed an important percentage of patients treated with catecholamine infusions, which was about 30% for both groups. Nevertheless, there are differences in the type of substance used. As De Backer's et al study showed neither norepinefrine nor dopamine had an advantage in the treatment of shock, with the exception of side effects, which were more frequent in the group of patients treated with dopamine [12] .
What is more, in current European Society of Cardiology (ESC) recommendations for the treatment of acute heart failure, the use of norepinefrine in shock is preferred over treatment with dopamine or dobutamine [13] .
Another important observation from the current study is a high percentage of IABP use. While in the ICU group it was used in only 3.4% of patients (most likely due to limited availability of the device), in the case of ICCU it reached over 13%. The result is not supported by any available scientific evidence. Moreover, the current recommendations have even recognized IABP as ineffective and potentially harmful [13] .
Moving to the analysis of the reported complications, 2 results are particularly noteworthy. Firstly, there were a very small number of reported cases of acute renal failure in the ICU (0% vs. 3.5% in ICCU). Perhaps the cause of this phenomenon was acute renal failure on the basis of contrast nephropathy as a consequence of more frequently performed coronary angiography in this group. Unfortunately, the registry does not provide separate data on the reasons for acute renal failure. The second observation concerns the frequency of pneumonia, which was also more common in the ICCU patients. In light of the equally frequent use of antibiotic prophylaxis in both groups (about 80%), the difference may be due to the more frequent use of bronchoscopy in the ICU than in ICCU. However, the occurrence of pneumonia did not affect the risk of death or the final neurological results. A similar observation was presented in a study by Mongardonet al, in which pneumonia was a neutral factor to death and neurological outcome, affecting only the length of hospitalization [14] . In the current analysis, frequency of other complications did not differ significantly between both groups and were in line with results presented in previous studies on the TTM [15] .
An important part of our study is a comparative analysis of neurological outcomes and deaths in both groups of patients. During the treatment, a total of 17% and 20% of patients died in the ICU and ICCU groups (p=0.57), respectively. The presented percentage is much lower compared to previous studies on the TTM, such as Nilsen's et al study, in which the mortality rate was 50% [16] . Perhaps this is due to the fact that the mentioned study carried out an early prognosis assessment (after 72 hours), on the basis of which patients considered to be severely or irreversibly damaged neurologically did not continue further intensive therapy. Previous studies showed clear neurological benefits in OHCA patients treated with TTM comparing to control groups [1, 17] . Meanwhile, as shown by the current study, a large percentage of patients who were initially (after discontinuing sedation) judged as a 4 or 5 class in the Rankin scale obtained good neurological results after further treatment. Reflecting on the neurological results of the current study, it might be highlighted that in the ICCU group there were more patients assessed as class 1, 2 or 3 in the Rankin scale, than in the ICU group.
The percentage of good neurological findings at the level of 32-43% appears to be a satisfactory result, comparable with the results of other studies on TTM [18] . It is also interesting to directly compare the overall results of treatment between our registry and the European registry [19] . It can be clearly observed that the survival rate in Poland was higher (69.2% vs 56%, respectively). However, while there was a similar level of good neurological results (39.4% vs 44%), the Polish patients were markedly more likely to have a poor neurological status (29.8% vs. 12%, respectively). It would also be interesting to find out how many of the patients discharged with a significant neurological deficit were then referred to a rehabilitation program, and what the distant neurological outcomes and mortality rate of the studied population are.
Conclusions
ICU become a considerable alternative to ICCU to treat OHCA patients. In our study the TTM in both units obtained similar survival rates and neurological results with a high percentage of good results and an acceptable level of poor neurological results. TTM was characterized by a good safety profile and a low number of complications. There is a clear need to carry out well-planned randomized trials in order to obtain further comparisons of treatment results in these groups of patients.
Limitations of the study
The main limitation of the presented study is the lack of randomized allocation of patients to both groups. What is more, the data gathered during the study was based on the prespecified questionnaire, therefore some data are limited. Various factors could have influenced quality of the data like: no certainty as to the accuracy of the reported times during the pre-hospital treatment period; the lack of information on the cause of death or acute renal failure.
The strength of the study is its observational nature and that it included data from both academic and non-academic centers. Therefore, it presents real-life data on treatment of OHCA patients. Despite the described limitations, our study is the first of its kind that attempts to compare the results of treatment of OHCA patients between ICU and ICCU departments. ICUintensive care unit; ICCUintensive cardiac care unit
